Integer Holdings Corporation (ITGR)
USD 112.93
(-0.68%)
USD 112.93
(-0.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.01 Billion USD | 3.44% |
| 2022 | 983.4 Million USD | 11.77% |
| 2021 | 879.87 Million USD | 20.8% |
| 2020 | 728.34 Million USD | -13.89% |
| 2019 | 845.85 Million USD | -6.01% |
| 2018 | 899.93 Million USD | -42.5% |
| 2017 | 1.56 Billion USD | -6.73% |
| 2016 | 1.67 Billion USD | 2.85% |
| 2015 | 1.63 Billion USD | 1374.19% |
| 2014 | 110.67 Million USD | -31.7% |
| 2013 | 162.03 Million USD | -21.01% |
| 2012 | 205.13 Million USD | 2.85% |
| 2011 | 199.44 Million USD | 0.86% |
| 2010 | 197.74 Million USD | -21.39% |
| 2009 | 251.55 Million USD | -23.97% |
| 2008 | 330.85 Million USD | 59.28% |
| 2007 | 207.72 Million USD | 110.14% |
| 2006 | 98.85 Million USD | -20.32% |
| 2005 | 124.06 Million USD | 50.96% |
| 2004 | 82.17 Million USD | 57.15% |
| 2003 | 52.29 Million USD | -34.95% |
| 2002 | 80.39 Million USD | 158.25% |
| 2001 | 31.13 Million USD | -8.31% |
| 2000 | 33.95 Million USD | -73.75% |
| 1999 | 129.35 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.17 Billion USD | -1.16% |
| 2024 Q1 | 1.19 Billion USD | 17.21% |
| 2024 Q3 | 1.04 Billion USD | -3.63% |
| 2023 Q3 | 984.03 Million USD | -3.95% |
| 2023 Q1 | 1.04 Billion USD | 5.95% |
| 2023 FY | 1.01 Billion USD | 3.44% |
| 2023 Q2 | 1.02 Billion USD | -1.67% |
| 2023 Q4 | 1.01 Billion USD | 3.38% |
| 2022 Q4 | 983.4 Million USD | -0.77% |
| 2022 Q1 | 878.92 Million USD | -0.11% |
| 2022 Q2 | 1 Billion USD | 14.54% |
| 2022 Q3 | 991.07 Million USD | -1.56% |
| 2022 FY | 983.4 Million USD | 11.77% |
| 2021 Q3 | 654.49 Million USD | -5.03% |
| 2021 Q2 | 689.19 Million USD | -3.17% |
| 2021 FY | 879.87 Million USD | 20.8% |
| 2021 Q1 | 711.78 Million USD | -2.27% |
| 2021 Q4 | 879.87 Million USD | 34.44% |
| 2020 Q4 | 728.34 Million USD | -7.39% |
| 2020 Q1 | 844.5 Million USD | -0.16% |
| 2020 Q2 | 810.29 Million USD | -4.05% |
| 2020 Q3 | 786.48 Million USD | -2.94% |
| 2020 FY | 728.34 Million USD | -13.89% |
| 2019 FY | 845.85 Million USD | -6.01% |
| 2019 Q4 | 845.85 Million USD | -0.71% |
| 2019 Q1 | 931.88 Million USD | 3.55% |
| 2019 Q3 | 851.92 Million USD | -3.93% |
| 2019 Q2 | 886.8 Million USD | -4.84% |
| 2018 Q3 | 931.31 Million USD | -38.72% |
| 2018 FY | 899.93 Million USD | -42.5% |
| 2018 Q4 | 899.93 Million USD | -3.37% |
| 2018 Q2 | 1.51 Billion USD | -0.81% |
| 2018 Q1 | 1.53 Billion USD | -2.1% |
| 2017 Q4 | 1.56 Billion USD | -1.34% |
| 2017 Q3 | 1.58 Billion USD | -2.0% |
| 2017 Q2 | 1.61 Billion USD | -1.75% |
| 2017 FY | 1.56 Billion USD | -6.73% |
| 2017 Q1 | 1.64 Billion USD | -1.82% |
| 2016 FY | 1.67 Billion USD | 2.85% |
| 2016 Q2 | 1.72 Billion USD | 0.69% |
| 2016 Q1 | 1.7 Billion USD | 4.71% |
| 2016 Q4 | 1.67 Billion USD | -1.36% |
| 2016 Q3 | 1.7 Billion USD | -1.11% |
| 2015 Q1 | 117.98 Million USD | 6.6% |
| 2015 Q2 | 110.16 Million USD | -6.63% |
| 2015 FY | 1.63 Billion USD | 1374.19% |
| 2015 Q3 | 111.4 Million USD | 1.13% |
| 2015 Q4 | 1.63 Billion USD | 1364.53% |
| 2014 FY | 110.67 Million USD | -31.7% |
| 2014 Q3 | 128.41 Million USD | -9.12% |
| 2014 Q4 | 110.67 Million USD | -13.82% |
| 2014 Q1 | 156.67 Million USD | -3.31% |
| 2014 Q2 | 141.3 Million USD | -9.81% |
| 2013 Q2 | 226.81 Million USD | 1.78% |
| 2013 Q1 | 222.85 Million USD | 8.64% |
| 2013 Q3 | 205.02 Million USD | -9.61% |
| 2013 Q4 | 162.03 Million USD | -20.97% |
| 2013 FY | 162.03 Million USD | -21.01% |
| 2012 Q3 | 219.31 Million USD | -1.32% |
| 2012 Q1 | 229.1 Million USD | 14.87% |
| 2012 FY | 205.13 Million USD | 2.85% |
| 2012 Q4 | 205.13 Million USD | -6.47% |
| 2012 Q2 | 222.24 Million USD | -3.0% |
| 2011 FY | 199.44 Million USD | 0.86% |
| 2011 Q4 | 199.44 Million USD | 27.29% |
| 2011 Q3 | 156.67 Million USD | -7.16% |
| 2011 Q2 | 168.76 Million USD | -1.58% |
| 2011 Q1 | 171.46 Million USD | -13.29% |
| 2010 FY | 197.74 Million USD | -21.39% |
| 2010 Q1 | 235.46 Million USD | -6.4% |
| 2010 Q4 | 197.74 Million USD | 0.81% |
| 2010 Q3 | 196.15 Million USD | -10.05% |
| 2010 Q2 | 218.06 Million USD | -7.39% |
| 2009 FY | 251.55 Million USD | -23.97% |
| 2009 Q2 | 288.82 Million USD | -3.88% |
| 2009 Q3 | 266.56 Million USD | -7.71% |
| 2009 Q4 | 251.55 Million USD | -5.63% |
| 2009 Q1 | 300.49 Million USD | -9.18% |
| 2008 Q2 | 337.93 Million USD | -2.43% |
| 2008 Q1 | 346.36 Million USD | 66.74% |
| 2008 FY | 330.85 Million USD | 59.28% |
| 2008 Q4 | 330.85 Million USD | -0.43% |
| 2008 Q3 | 332.3 Million USD | -1.67% |
| 2007 Q1 | 92.98 Million USD | -5.94% |
| 2007 FY | 207.72 Million USD | 110.14% |
| 2007 Q4 | 207.72 Million USD | 43.33% |
| 2007 Q3 | 144.92 Million USD | -8.85% |
| 2007 Q2 | 158.99 Million USD | 71.0% |
| 2006 Q1 | 131.27 Million USD | 5.82% |
| 2006 FY | 98.85 Million USD | -20.32% |
| 2006 Q3 | 114.2 Million USD | -9.23% |
| 2006 Q4 | 98.85 Million USD | -13.44% |
| 2006 Q2 | 125.82 Million USD | -4.16% |
| 2005 FY | 124.06 Million USD | 50.96% |
| 2005 Q1 | 92.43 Million USD | 12.48% |
| 2005 Q2 | 88.02 Million USD | -4.78% |
| 2005 Q3 | 131.44 Million USD | 49.33% |
| 2005 Q4 | 124.06 Million USD | -5.62% |
| 2004 FY | 82.17 Million USD | 57.15% |
| 2004 Q4 | 82.17 Million USD | -12.71% |
| 2004 Q3 | 94.14 Million USD | 2.03% |
| 2004 Q2 | 92.27 Million USD | -5.11% |
| 2004 Q1 | 97.23 Million USD | 85.95% |
| 2003 Q1 | 77.29 Million USD | -3.85% |
| 2003 Q3 | 58.82 Million USD | -18.26% |
| 2003 Q2 | 71.97 Million USD | -6.89% |
| 2003 Q4 | 52.29 Million USD | -11.11% |
| 2003 FY | 52.29 Million USD | -34.95% |
| 2002 FY | 80.39 Million USD | 158.25% |
| 2002 Q3 | 82.42 Million USD | 165.07% |
| 2002 Q1 | 33.84 Million USD | 8.73% |
| 2002 Q2 | 31.09 Million USD | -8.13% |
| 2002 Q4 | 80.39 Million USD | -2.47% |
| 2001 FY | 31.13 Million USD | -8.31% |
| 2001 Q1 | 35.67 Million USD | 5.08% |
| 2001 Q2 | 79.56 Million USD | 123.01% |
| 2001 Q3 | 36.78 Million USD | -53.77% |
| 2001 Q4 | 31.13 Million USD | -15.37% |
| 2000 FY | 33.95 Million USD | -73.75% |
| 2000 Q4 | 33.95 Million USD | -72.34% |
| 2000 Q3 | 122.73 Million USD | 0.0% |
| 1999 FY | 129.35 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 88.668% |
| Allurion Technologies Inc. | 3.82 Million USD | -26530.419% |
| Artivion, Inc. | 300.4 Million USD | -238.641% |
| Avanos Medical, Inc. | 121.4 Million USD | -737.959% |
| Butterfly Network, Inc. | -109.6 Million USD | 1028.101% |
| Butterfly Network, Inc. | -109.6 Million USD | 1028.101% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | -1.532% |
| Boston Scientific Corporation | 8.62 Billion USD | 88.208% |
| CONMED Corporation | 966.95 Million USD | -5.204% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 326.516% |
| Paragon 28, Inc. | 36.39 Million USD | -2695.422% |
| Glaukos Corporation | 290.27 Million USD | -250.459% |
| Globus Medical, Inc. | 53.11 Million USD | -1815.352% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 733.067% |
| Medtronic plc | 24.76 Billion USD | 95.892% |
| Myomo, Inc. | -6.27 Million USD | 16324.586% |
| Nevro Corp. | 117.61 Million USD | -764.962% |
| Owlet, Inc. | -1.34 Million USD | 75960.012% |
| Penumbra, Inc. | 66.85 Million USD | -1421.579% |
| Vicarious Surgical Inc. | -37.99 Million USD | 2777.763% |
| Smith & Nephew plc | 2.78 Billion USD | 63.433% |
| Sonendo, Inc. | 26.34 Million USD | -3761.825% |
| STERIS plc | 3.17 Billion USD | 67.971% |
| Stryker Corporation | 10.02 Billion USD | 89.852% |
| Vapotherm, Inc. | 102.66 Million USD | -890.856% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 81.767% |